Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicentric, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog Glargine Plus Glulisine With Premixed Insulin in Adult Patients With Type 2 Diabetes Mellitus

NCT02987751 is registered in ClinicalTrials.gov with India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals as lead sponsor.

NCT NCT02987751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02987751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicentric, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog Glargine Plus Glulisine With Premixed Insulin in Adult Patients With Type 2 Diabetes Mellitus
Lead sponsor
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
Phase
Phase 4
Overall status
Completed
Start date
December 29, 2016
Completion date
June 30, 2019
Enrollment
200 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes